Procter & Gamble Health Limited
NSE: PGHL BSE: PGHL
NSE
6,152.00
-24.50 (-0.40%)
Prev Close
6176.5
Open Price
6188.5
Volume
17,413
Today Low / High
6112 / 6228
52 WK Low / High
4903.85 / 6739
Range
5,844 - 6,460
BSE
6,174.35
-6.95 (-0.11%)
Prev Close
6181.3
Open Price
6134
Volume
418
Today Low / High
6105.55 / 6206.05
52 WK Low / High
4916 / 6700
Range
5,866 - 6,483
The stock is currently trading on both the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE). On the NSE, the stock is priced at 6152 (target range: 5,844 - 6,460), reflecting a change of -24.5 (-0.39666%). On the BSE, it is listed at 6174.35 (target range: 5,866 - 6,483), showing a change of -6.95 (-0.11244%). The stock price is currently in decline on both exchanges, signaling a downtrend. If you're considering investing in this stock, it's important to monitor the situation closely.
31 Oct
6,188.50
-0.12%
30 Oct
6,183.50
-0.11%
29 Oct
6,221.00
-0.50%
28 Oct
6,168.50
0.24%
27 Oct
6,083.00
1.27%
24 Oct
6,095.00
-0.19%
23 Oct
6,196.00
-1.29%
21 Oct
6,182.00
-0.16%
20 Oct
6,240.00
-1.52%
17 Oct
6,347.00
-1.62%
16 Oct
6,173.00
1.81%
15 Oct
6,132.00
0.67%
14 Oct
6,118.50
0.21%
13 Oct
6,241.00
-1.96%
10 Oct
6,072.50
2.08%
09 Oct
6,230.00
-2.53%
08 Oct
6,234.50
0.00%
07 Oct
6,185.00
0.80%
06 Oct
6,271.50
-1.12%
03 Oct
6,305.00
-0.53%
Procter & Gamble Health Limited Graph
Procter & Gamble Health Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges
If you are looking for the target price for Procter & Gamble Health Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 6,152.00, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.
| Scenario | Price | Target | Range |
|---|---|---|---|
| Bullish Scenario | 6,174.35 | 6,236.09 | 5,612.48 - 6,859.70 |
| 6,297.84 | 5,038.27 - 7,557.40 | ||
| 6,359.58 | 4,451.71 - 8,267.45 | ||
| Bearish Scenario | 6,174.35 | 6,112.61 | 5,501.35 - 6,723.87 |
| 6,050.86 | 4,840.69 - 7,261.04 | ||
| 5,989.12 | 4,192.38 - 7,785.86 |
Overview of Procter & Gamble Health Limited
ISIN
INE199A01012
Industry
Drug Manufacturers - Specialty & Generic
Vol.Avg
15,896
Market Cap
102,019,801,772
Last Dividend
125
Official Website
IPO Date
2002-07-01
DCF Diff
-1,884.35
DCF
8,061
Financial Ratios Every Investor Needs
Stock Dividend of PGHL
| Date | Label | Adj Dividend | Dividend | Record Date | Payment Date | Declaration Date |
|---|---|---|---|---|---|---|
| 2025-08-22 | August 22, 25 | 45 | 45 | 2025-08-22 | 2025-09-25 | |
| 2025-02-21 | February 21, 25 | 80 | 80 | 2025-02-21 | 2025-03-07 | |
| 2024-11-28 | November 28, 24 | 60 | 60 | 2024-11-28 | 2024-12-25 | |
| 2024-02-14 | February 14, 24 | 200 | 200 | 2024-02-14 | 2024-03-03 | |
| 2023-11-23 | November 23, 23 | 50 | 50 | 2023-11-23 | 2023-12-30 |
Annual Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | R&D Expenses | G&A Expenses | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 1,218.05 Cr | 348.97 Cr | 869.08 Cr | 0.7135 | 2.61 Cr | 190.97 Cr | 633.17 Cr | 251.19 Cr | 151.33 | 362.09 Cr | 0.2062 |
| 2024-03-31 | 1,151.26 Cr | 342.54 Cr | 808.72 Cr | 0.7025 | 3.86 Cr | 215.53 Cr | 536.68 Cr | 200.98 Cr | 121.08 | 303.41 Cr | 0.1746 |
| 2023-03-31 | 1,229.62 Cr | 383.37 Cr | 846.25 Cr | 0.6882 | 5.71 Cr | 206.64 Cr | 559.41 Cr | 229.47 Cr | 138.24 | 318.75 Cr | 0.1866 |
| 2022-03-31 | 1,114.41 Cr | 353.05 Cr | 761.36 Cr | 0.6832 | 6.55 Cr | 168.19 Cr | 477.17 Cr | 192.52 Cr | 115.98 | 264.77 Cr | 0.1728 |
| 2021-03-31 | 1,008.73 Cr | 324.51 Cr | 684.22 Cr | 0.6783 | 3.93 Cr | 155.19 Cr | 437.69 Cr | 176.80 Cr | 106.51 | 242.40 Cr | 0.1753 |
Annual Financials Balance Sheet
| Date | C&C Equ. | Tot. Assets | Tot. Liab. | Stock. Equity | Tot. Debt | Net Debt | Inv. | PP&E (Net) | Curr. Def. Rev. | Non-Curr. Def. Rev. | LT Invest. | Curr. Liab. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 188.55 Cr | 794.20 Cr | 257.24 Cr | 536.9600 Cr | 7.62 Cr | -180.93 Cr | 109.37 Cr | 121.99 Cr | 0.00 Cr | 0.00 Cr | 19.33 Cr | 215.3100 Cr |
| 2024-06-30 | 244.36 Cr | 794.36 Cr | 256.12 Cr | 538.2400 Cr | 9.56 Cr | -234.80 Cr | 109.11 Cr | 131.53 Cr | 0.00 Cr | 0.00 Cr | 11.64 Cr | 218.9100 Cr |
| 2023-06-30 | 435.05 Cr | 1,101.19 Cr | 350.30 Cr | 750.8900 Cr | 12.00 Cr | -423.05 Cr | 134.94 Cr | 173.27 Cr | 54.82 Cr | 0.00 Cr | -12.64 Cr | 303.9000 Cr |
| 2022-06-30 | 319.40 Cr | 893.72 Cr | 277.23 Cr | 616.4900 Cr | 2.83 Cr | -316.57 Cr | 115.21 Cr | 149.62 Cr | 0.56 Cr | 0.00 Cr | -3.83 Cr | 235.8300 Cr |
| 2021-06-30 | 464.05 Cr | 986.16 Cr | 282.45 Cr | 703.7100 Cr | 7.61 Cr | -456.44 Cr | 118.37 Cr | 140.13 Cr | 97.22 Cr | 0.00 Cr | -2.66 Cr | 238.9700 Cr |
Annual Financials Cash Flow Statement
| Date | Operating Cash | Investing Cash | Financing Cash | Free Cash | Cash Change | Cash at End | CapEx | Income | Debt Repay | Dividends | Inventory |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 175.8400 Cr | 2.4400 Cr | -234.7400 Cr | 167.2800 Cr | -251.6700 Cr | 188.5500 Cr | -8.5600 Cr | 312.5459 Cr | 0.0000 Cr | -232.4000 Cr | -2.3700 Cr |
| 2024-06-30 | 228.2800 Cr | -6.8700 Cr | -418.1100 Cr | 206.5600 Cr | -196.6900 Cr | 238.7300 Cr | -21.7300 Cr | 200.9800 Cr | 0.0000 Cr | -414.9900 Cr | 23.1300 Cr |
| 2023-06-30 | 236.0000 Cr | -21.5000 Cr | -98.4700 Cr | 193.5200 Cr | 116.0200 Cr | 435.4200 Cr | -42.4800 Cr | 314.2000 Cr | 0.0000 Cr | -93.7900 Cr | -32.3900 Cr |
| 2022-06-30 | 169.5200 Cr | -25.5400 Cr | -288.6300 Cr | 131.6000 Cr | -144.6500 Cr | 319.4000 Cr | -37.9200 Cr | 253.3700 Cr | 0.0000 Cr | -283.8500 Cr | -2.0200 Cr |
| 2021-06-30 | 247.2600 Cr | -32.2700 Cr | -386.6300 Cr | 194.6800 Cr | -171.6400 Cr | 464.0500 Cr | -52.5800 Cr | 233.2800 Cr | 0.0000 Cr | -381.7800 Cr | 15.2600 Cr |
Quarterly Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|
| 2025-06-30 | 338.74 Cr | 93.99 Cr | 244.75 Cr | 0.7225 | 188.74 Cr | 66.18 Cr | 39.87 | 90.34 Cr | 0.1954 |
| 2025-03-31 | 310.99 Cr | 98.72 Cr | 212.27 Cr | 0.6826 | 163.48 Cr | 61.18 Cr | 36.86 | 80.92 Cr | 0.1967 |
| 2024-12-31 | 309.77 Cr | 75.73 Cr | 234.04 Cr | 0.7555 | 186.99 Cr | 90.90 Cr | 54.76 | 123.54 Cr | 0.2934 |
| 2024-09-30 | 338.74 Cr | 93.99 Cr | 244.75 Cr | 0.7225 | 188.74 Cr | 66.18 Cr | 39.87 | 90.34 Cr | 0.1954 |
| 2024-06-30 | 283.88 Cr | 79.17 Cr | 204.71 Cr | 0.7211 | 156.08 Cr | 16.78 Cr | 10.11 | 48.25 Cr | 0.0591 |
Quarterly Financials Balance Sheet
| Date | Cash & Equiv. | Short-Term Inv. | Cash & Short-Term | Net Receivables | Inventory | Total Curr. Assets | PP&E (Net) | Total Assets | Total Liabilities |
|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 182.08 Cr | 23.98 Cr | 206.06 Cr | 146.99 Cr | 109.37 Cr | 526.39 Cr | 121.99 Cr | 794.20 Cr | 257.24 Cr |
| 2024-12-31 | 266.43 Cr | 25.83 Cr | 292.26 Cr | 132.24 Cr | 118.78 Cr | 612.49 Cr | 125.27 Cr | 870.15 Cr | 259.69 Cr |
| 2024-09-30 | 0.00 Cr | 0.00 Cr | 244.36 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -538.24 Cr |
| 2024-06-30 | 244.36 Cr | 0.00 Cr | 244.36 Cr | 85.33 Cr | 109.11 Cr | 524.22 Cr | 131.53 Cr | 794.36 Cr | 256.12 Cr |
| 2024-03-31 | -425.56 Cr | 851.12 Cr | 425.56 Cr | 0.00 Cr | 0.00 Cr | 425.56 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
Quarterly Financials Cash Flow Statement
| Date | Net Income | Operating Cash Flow | Investing Cash Flow | Financing Cash Flow | Net Cash Change | Cash at End | Cash at Beginning | CapEx | Free Cash Flow |
|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 78.53 Cr | 49.22 Cr | -0.05 Cr | -133.58 Cr | -84.41 Cr | 182.27 Cr | 266.68 Cr | -3.23 Cr | 45.99 Cr |
| 2024-12-31 | 90.90 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-09-30 | 82.33 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-06-30 | 16.78 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-03-31 | 46.56 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
Splits History
| Date | Label | Split Ratio |
|---|---|---|
| No split history data available. | ||
Similar Stocks: Drug Manufacturers - Specialty & Generic
| Company Name | Symbol | Price | Market Cap | Volume |
|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | SUNPHARMA | ₹1,690.70 | ₹4,056,549,508,373.00 | ₹1,560,907.00 |
| Divi's Laboratories Limited | DIVISLAB | ₹6,738.00 | ₹1,788,732,898,056.00 | ₹507,645.00 |
| Torrent Pharmaceuticals Limited | TORNTPHARM | ₹3,560.10 | ₹1,204,898,044,500.00 | ₹354,021.00 |
| Dr. Reddy's Laboratories Limited | DRREDDY | ₹1,197.60 | ₹996,839,216,220.00 | ₹4,250,056.00 |
| Mankind Pharma Limited | MANKIND | ₹2,384.00 | ₹984,016,240,160.00 | ₹593,366.00 |
| Zydus Lifesciences Limited | ZYDUSLIFE | ₹974.45 | ₹980,520,395,716.00 | ₹458,971.00 |
| Lupin Limited | LUPIN | ₹1,963.50 | ₹896,844,333,000.00 | ₹1,017,447.00 |
| Aurobindo Pharma Limited | AUROPHARMA | ₹1,138.90 | ₹661,474,968,435.00 | ₹3,556,831.00 |
| Alkem Laboratories Limited | ALKEM | ₹5,506.50 | ₹658,384,672,500.00 | ₹178,327.00 |
| Glenmark Pharmaceuticals Limited | GLENMARK | ₹1,891.20 | ₹533,698,169,981.00 | ₹398,054.00 |
| Laurus Labs Limited | LAURUSLABS | ₹953.65 | ₹514,804,014,931.00 | ₹1,545,364.00 |
| Suven Pharmaceuticals Limited | SUVENPHAR | ₹1,078.00 | ₹412,407,234,624.00 | ₹1,177,218.00 |
| Ipca Laboratories Limited | IPCALAB | ₹1,271.20 | ₹322,508,801,922.00 | ₹106,442.00 |
| Ajanta Pharma Limited | AJANTPHARM | ₹2,465.30 | ₹308,003,793,847.00 | ₹102,941.00 |
| Cohance Lifesciences Limited | COHANCE | ₹753.40 | ₹288,226,083,276.00 | ₹1,868,840.00 |
| J. B. Chemicals & Pharmaceuticals Limited | JBCHEPHARM | ₹1,682.30 | ₹263,441,852,870.00 | ₹161,890.00 |
| Piramal Enterprises Limited | PEL | ₹1,124.20 | ₹254,856,250,172.00 | ₹2,148,582.00 |
| Emcure Pharmaceuticals Ltd. | EMCURE | ₹1,318.90 | ₹250,017,076,708.00 | ₹201,166.00 |
| AstraZeneca Pharma India Limited | ASTRAZEN | ₹9,555.00 | ₹238,875,000,000.00 | ₹20,033.00 |
| Eris Lifesciences Limited | ERIS | ₹1,591.70 | ₹216,811,113,902.00 | ₹40,393.00 |
| Neuland Laboratories Limited | NEULANDLAB | ₹16,473.00 | ₹211,346,761,497.00 | ₹44,604.00 |
| Wockhardt Limited | WOCKPHARMA | ₹1,281.50 | ₹208,224,272,482.00 | ₹289,135.00 |
| Alembic Pharmaceuticals Limited | APLLTD | ₹897.40 | ₹176,395,747,478.00 | ₹69,233.00 |
| Jubilant Pharmova Limited | JUBLPHARMA | ₹1,101.00 | ₹174,564,413,184.00 | ₹543,954.00 |
| Caplin Point Laboratories Limited | CAPLIPOINT | ₹2,032.80 | ₹154,516,575,629.00 | ₹43,860.00 |
| NATCO Pharma Limited | NATCOPHARM | ₹819.90 | ₹146,852,182,413.00 | ₹412,467.00 |
| Granules India Limited | GRANULES | ₹565.60 | ₹137,253,425,770.00 | ₹384,397.00 |
| Glenmark Life Sciences Limited | GLS | ₹1,086.00 | ₹133,070,838,000.00 | ₹130,938.00 |
| Alivus Life Sciences Ltd. | ALIVUS | ₹904.45 | ₹110,959,145,199.00 | ₹27,710.00 |
| Procter & Gamble Health Limited | PGHL | ₹6,152.00 | ₹102,119,398,064.00 | ₹17,413.00 |
| Strides Pharma Science Limited | STAR | ₹934.70 | ₹86,153,835,776.00 | ₹9,219,602.00 |
| Aarti Pharmalabs Limited | AARTIPHARM | ₹851.95 | ₹77,214,757,940.00 | ₹105,286.00 |
| FDC Limited | FDC | ₹460.65 | ₹74,998,465,195.00 | ₹252,540.00 |
| Akums Drugs & Pharmaceuticals Ltd. | AKUMS | ₹460.75 | ₹70,541,773,224.00 | ₹53,334.00 |
| Shilpa Medicare Limited | SHILPAMED | ₹352.85 | ₹69,011,043,776.00 | ₹149,611.00 |
| Sequent Scientific Limited | SEQUENT | ₹214.61 | ₹53,633,796,524.00 | ₹1,034,635.00 |
| Gujarat Themis Biosyn Ltd. | GUJTHEM | ₹465.10 | ₹50,679,744,752.00 | ₹51,856.00 |
| Innova Captab Limited | INNOVACAP | ₹831.10 | ₹47,559,638,492.00 | ₹13,222.00 |
| Aarti Drugs Limited | AARTIDRUGS | ₹491.10 | ₹44,822,697,000.00 | ₹54,690.00 |
| Sun Pharma Advanced Research Company Limited | SPARC | ₹135.19 | ₹43,872,073,482.00 | ₹196,488.00 |
| Suven Life Sciences Limited | SUVEN | ₹197.55 | ₹43,073,939,692.00 | ₹121,404.00 |
| RPG Life Sciences Limited | RPGLIFE | ₹2,403.90 | ₹39,758,138,159.00 | ₹6,281.00 |
| Orchid Pharma Limited | ORCHPHARMA | ₹726.30 | ₹36,837,285,962.00 | ₹86,074.00 |
| Unichem Laboratories Limited | UNICHEMLAB | ₹470.95 | ₹33,157,587,963.00 | ₹3,282.00 |
| Gufic Biosciences Limited | GUFICBIO | ₹325.40 | ₹32,631,927,452.00 | ₹54,623.00 |
Key Executives
Assistant Company Secretary
Ms. Prachi Vichare
Gender: female
Year Born:
Company Secretary & Compliance Officer
Ms. Zeal Rupani
Gender: female
Year Born:
Chief Financial Officer, Finance Head & Executive Director
Mr. Lokesh Chandak
Gender: male
Year Born: 1987
MD & Executive Director
Mr. Milind Vasant Thatte M.B.A.
Gender: male
Year Born: 1969
FAQs about Procter & Gamble Health Limited
Who is the CEO of the company?
The CEO is Milind Vasant Thatte.
What is the current market price of the stock?
The current price is ₹6,146.00.
What is the 52-week price range?
The range is ₹4903.85-6739.
What is the market capitalization of the company?
The market capitalization is ₹10,201.98 crores.
What is the dividend yield?
The dividend yield is 3.01%.
What is the Price-to-Earnings (P/E) ratio?
The P/E ratio is 33.94.
Which sector does the company belong to?
The company operates in the Healthcare sector.
What does the company do?
Overview of Procter & Gamble Health Limited (ISIN: INE199A01012) is a leading Drug Manufacturers - Specialty & Generic in India. With a market capitalization of ₹10,201.98 crores and an average daily volume of 15,896 shares, it operates in the Drug Manufacturers - Specialty & Generic. The company last declared a dividend of ₹125.